Focus Groups
6
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
3 treatments under study, led by Focus Groups
Research Leaders
6 sponsors active, led by University of California, San Francisco
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (6)
Development of Web-Based Mind-Body Trainings for Adults With Subjective Concerns
COACH-Cog Intervention Adaptation Focus Groups
Using Focus Groups to Explore Perceptions of Adults With Low Socioeconomic Status Regarding the NutriQuébec Study
Study Of PHarmacogenetics in Ethnically Diverse Populations (SOPHIE Study)
Effect of, OAT3, on the Renal Secretion of Cefotaxime
The Laryngeal Tube Suction Versus Endotracheal Tube for Ventilation in Gynecological Laparoscopic Surgery
Research Network
Common Treatments
- Focus Groups2
- Laryngeal Tube Vbm Medizintechnik Sulz Germany1
- Cefotaxime1
Active Sponsors
- University of California, San Francisco2
- National Institute on Aging (NIA)1
- Laval University1
- Ohio State University1
- Prince of Songkla University1
Top Investigators
Laval University
University of California, San Francisco
Ohio State University
University of California, San Francisco
Related Conditions
- Aging1